Formulary, not routinely stocked, restricted to infectious diseases for initiation of therapy for patients with severe malaria with laboratory evidence of severe disease and/or major signs of organ dysfunction (i.e. altered consciousness, seizures, respiratory distress/ARDS, renal  failure, jaundice, DIC, severe anemia, hypoglycemia, circulatory dysfunction, others) and not able to take oral medication.

Interim treatment with an effective oral antimalarial agent  [artemether-lumefantrine (COARTEM)] should be started as soon as possible.

Reviewed:  Oct. 2021

• Micromedex
• UpToDate
• Lippincott Advisor